Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide for impaired awareness of hypoglycemia in adults with type 1 diabetes
NL-OMON45806Phase 2Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Feb 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetes mellitus type 1 (T1D) comparing Exenatide + insulin with Placebo + insulin (2 arms). Primary endpoint: Symptom score in response to the hyperinsulinemic hypoglycemic glucose clamp experiment. Started Feb 2017; status: active, not recruiting.
02
Drugs
exenatide
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on NL-OMON45806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45806.